Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Nov 28, 2017; 23(44): 7863-7874
Published online Nov 28, 2017. doi: 10.3748/wjg.v23.i44.7863
Table 6 Predictive performances of prognostic models for hepatocellular carcinoma development
Categorical variableRotterdamParis IBarcelonaTorontoCirrhosisThrombocytopenia, < 150 × 109/LHyperbilirubinemia,> 17 mmol/L
AUROC0.680.670.640.640.710.750.64
(95%CI)(0.52-0.80)(0.52-0.81)(0.48-0.78)(0.47-0.78)(0.56-0.86)(0.58-0.90)(0.49-0.77)
Sensitivity75.00%66.60%58.30%63.60%66.70%70.00%66.70%
Specificity60.60%66.60%68.90%63.60%75.00%79.00%60.80%
PPV14.80%15.40%14.60%14.00%19.50%21.20%13.60%
NPV96.40%95.70%94.80%94.90%96.10%97.00%84.90%
Continuous variableAPRIAPRI-r1Mayo risk scoreMELD scoreCP score
AUROC0.680.770.70.630.62
(95%CI)(0.49-0.87)(0.64-0.88)(0.54-0.84)(0.43-0.79)(0.47-0.76)
Sensitivity-----
Specificity-----
PPV-----
NPV-----